A Comparative Study of Intravaginal Misoprostol with and without Isosorbide Mononitrate for Induction of Second-Trimester Abortion (Code-T0143)
Keywords:
Misoprostol, Isosorbide mononitrate, Second-trimester abortion, Cervical ripening, Induction-to-abortion interval, Randomized controlled trial.Synopsis
Introduction: Second-trimester abortions are associated with increased maternal morbidity and mortality compared to first-trimester procedures. Pharmacological agents such as misoprostol, a prostaglandin E1 analog, are commonly used for cervical ripening and uterine contractions. The addition of isosorbide mononitrate (IMN), a nitric oxide donor, may enhance cervical ripening and improve outcomes.
Aims and Objectives:
Aim:
- To study the role of intravaginal misoprostol with and without isosorbide mononitrate intravaginally in the induction of second-trimester abortion
Objectives:
- Evaluating efficacy of misoprostol plus isosorbide mononitrate in induction of second-trimester abortion.
- To study the efficacy of only. misoprostol for terminating pregnancies in the second trimester
- comparing efficacy of both the groups by analyzingdifferences in success rate of initiating abortion, induction-expulsion duration, need for operative interference and the rate of post-abortive haemorrhage.
- To compare safety profile and overall patient satisfaction rate in both the group.
Methods: A randomized controlled trial was conducted involving women requiring second-trimester abortion. Participants were divided into two groups: Group A received intravaginal misoprostol alone, and Group B received misoprostol with IMN intravaginally. The primary outcomes were induction-to-abortion interval, success rate within 24 hours, and adverse events. Secondary outcomes included patient acceptability and need for surgical intervention. Data were analyzed using statistical software, with significance set at p < 0.05.
Results: Group B demonstrated a significantly shorter induction-to-abortion interval compared to Group A (p < 0.05). The success rate within 24 hours was higher in Group B. Adverse events, including abdominal pain and nausea, were comparable between groups. Patient acceptability was higher in Group B.
Conclusion: The combination of intravaginal misoprostol and IMN is more effective than misoprostol alone for second-trimester abortion, with a shorter induction-to-abortion interval and higher success rates, without an increase in adverse effects. Further studies are warranted to confirm these findings.
Keywords: Misoprostol, Isosorbide mononitrate, Second-trimester abortion, Cervical ripening, Induction-to-abortion interval, Randomized controlled trial.
